,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2012-01-23 07:30:00,"Colgate-Palmolive Company ( CL ), one of the leading global consumer product manufacturers, is scheduled to report its fourth-quarter 2011 financial results before the market opens on January 26, 2012.",0.16285140812397003,0.006871738936752081,0.8302767872810364,neutral,0.15597966313362122
1,2012-01-23 07:30:00,The current Zacks Consensus Estimate for the quarter is earnings of $1.30 a share.,0.1389915496110916,0.022298727184534073,0.8387097716331482,neutral,0.11669282615184784
2,2012-01-23 07:30:00,"For the quarter under review, revenue is expected to be $4,219 million, according to the Zacks Consensus Estimate.",0.022743254899978638,0.018671462312340736,0.9585853219032288,neutral,0.004071792587637901
3,2012-01-23 07:30:00,"Colgate-Palmolive posted earnings of $1.31 per share for third-quarter 2011, remaining in line with the Zacks Consensus Estimate.",0.9077927470207214,0.05938281863927841,0.032824330031871796,positive,0.8484099507331848
4,2012-01-23 07:30:00,Earnings surpassed the prior-year quarter figure of $1.21 per share by 8.2%.,0.9470338225364685,0.03368044272065163,0.019285699352622032,positive,0.9133533835411072
5,2012-01-23 07:30:00,"Global net sales increased 11.2% year over year to $4,383 million based on 2% surge in pricing and 4.5% rise in foreign exchange coupled with a 4.5% addition from global unit volume.",0.9601977467536926,0.019884498789906502,0.019917771220207214,positive,0.9403132200241089
6,2012-01-23 07:30:00,"On an organic basis (excluding foreign exchange, acquisitions and divestitures), sales increased 5% in the quarter.",0.9563758969306946,0.016761044040322304,0.02686307393014431,positive,0.9396148324012756
7,2012-01-23 07:30:00,"Global net sales beat the Zacks Consensus Revenue Estimate of $4,374 million.",0.9455041289329529,0.02747219242155552,0.027023736387491226,positive,0.9180319309234619
8,2012-01-23 07:30:00,"The analyst covered by Zacks expects Colgate-Palmolive to post fourth-quarter 2011 earnings of $1.30 a share, higher than $1.24 delivered in the prior-year quarter.",0.9544636011123657,0.020746789872646332,0.024789610877633095,positive,0.9337168335914612
9,2012-01-23 07:30:00,"Currently, the Zacks Consensus Estimate ranges between earnings of $1.24 and $1.35 a share.",0.041080109775066376,0.009075337089598179,0.9498445391654968,neutral,0.03200477361679077
10,2012-01-23 07:30:00,"For fiscal 2011, the Zacks Consensus Estimate stood at $5.02 per share, higher than the previous fiscal earnings of $4.84.",0.9447907209396362,0.025304220616817474,0.029905110597610474,positive,0.9194865226745605
11,2012-01-23 07:30:00,The current Zacks estimate ranges between $4.97 and $5.07 per share.,0.01817566156387329,0.013316049240529537,0.9685083031654358,neutral,0.004859612323343754
12,2012-01-23 07:30:00,"For the fourth quarter of fiscal 2011, of the 21 analysts covering the stock, 4 analysts revised their estimates downward, while none has revised in the opposite direction in the last 30 days.",0.027124695479869843,0.8643354177474976,0.10853994637727737,negative,-0.8372107148170471
13,2012-01-23 07:30:00,"For full fiscal 2011, 4 analysts revised their estimates in negative direction, while 1 revised in positive direction, in the last 30 days.",0.04730013757944107,0.7788511514663696,0.17384861409664154,negative,-0.7315509915351868
14,2012-01-23 07:30:00,"In the last 7 days, 2 out of 21 analysts have revised their estimates in the negative direction for the fourth quarter as well as for fiscal 2011.",0.029430584982037544,0.8965947031974792,0.07397465407848358,negative,-0.867164134979248
15,2012-01-23 07:30:00,"Despite negative estimate revision by most of the analysts, the Zacks Consensus Estimates remained stagnant at $1.30 for the fourth quarter, over the last 7 and 30 days.",0.03792267292737961,0.8973696827888489,0.06470763683319092,negative,-0.8594470024108887
16,2012-01-23 07:30:00,"However, for fiscal 2011, the Zacks Consensus Estimate contracted by a penny to $5.02 per share over the last 7 days.",0.05503251031041145,0.9349782466888428,0.009989187121391296,negative,-0.8799457550048828
17,2012-01-23 07:30:00,"With respect to earnings surprises, Colgate-Palmolive has met as well as topped the Zacks Consensus Estimate over the last four quarters in the range of 0.0% to 0.8%.",0.9448740482330322,0.02037978358566761,0.034746117889881134,positive,0.9244942665100098
18,2012-01-23 07:30:00,The average remained at positive 0.8%.,0.5307971835136414,0.19308701157569885,0.27611586451530457,positive,0.3377101719379425
19,2012-01-23 07:30:00,This suggests that Colgate-Palmolive has surpassed the Zacks Consensus Estimate by an average of 0.8% in the trailing four quarters.,0.9524378776550293,0.02582508884370327,0.02173698879778385,positive,0.9266127943992615
20,2012-01-23 07:30:00,"We believe that, Colgate-Palmolive's continued focus on innovation and development of new products will facilitate it in enhancing its customer base while increasing market share.",0.9461125731468201,0.01500748936086893,0.03887997940182686,positive,0.9311050772666931
21,2012-01-23 07:30:00,"Moreover, the company's strategy of acquiring businesses with potential for generating higher top-line growth and margin will boost its future growth.",0.9500014781951904,0.015636608004570007,0.034361906349658966,positive,0.9343648552894592
22,2012-01-23 07:30:00,"However, Colgate-Palmolive operates in an intensely competitive environment.",0.7163612842559814,0.01682502217590809,0.266813725233078,positive,0.6995362639427185
23,2012-01-23 07:30:00,The resurgence of archrival Procter & Gamble Company ( PG ) has signaled new challenges.,0.7798610329627991,0.05911819636821747,0.16102083027362823,positive,0.7207428216934204
24,2012-01-23 07:30:00,"Global competitive conditions have also intensified, and Colgate is facing strong competition in China, Russia, India, Hong Kong, Brazil and Mexico.",0.9424185752868652,0.014488640241324902,0.043092742562294006,positive,0.9279299378395081
25,2012-01-23 07:30:00,"Currently, Colgate-Palmolivemaintains a Zacks #4 Rank, which translates into a short-term 'Sell' recommendation.",0.21070103347301483,0.013608800247311592,0.7756901383399963,neutral,0.1970922350883484
26,2012-01-23 07:30:00,Our long-term recommendation on the stock remains 'Neutral'.,0.0317763015627861,0.04951634630560875,0.9187073111534119,neutral,-0.017740044742822647
27,2012-01-23 07:30:00,To read this article on Zacks.com click here.,0.017961200326681137,0.01924508437514305,0.9627937078475952,neutral,-0.001283884048461914
28,2012-01-23 07:30:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
